Literature DB >> 24996935

Importance of specific reference values for evaluation of the deteriorating thyroid function in patients with end-stage renal disease on hemodialysis.

Toru Sanai1,2,3, Ken Okamura4, Tomoya Kishi5, Motoaki Miyazono5, Yuji Ikeda5, Takanari Kitazono4.   

Abstract

BACKGROUND/AIM: We evaluated the thyroid function in end-stage renal disease (ESRD) on maintenance hemodialysis. MATERIAL/
METHODS: Thyroid function and clinical hypothyroid score were evaluated in 145 ESRD patients.
RESULTS: Comparison of thyroid function between 127 ESRD patients, excluding 18 patients with suppressed or elevated serum TSH level, and age/sex-matched healthy controls (76 in midlife group aged under 65 and 51 in late-life group aged 65 or over) using a multivariate logistic regression analysis suggested significant difference (P < 0.0001), mainly in serum fT4 level (P = 0.0099) and age (P = 0.0492), but not in serum fT3 (not significant; ns), TSH (ns) level or fT3/fT4 ratio (ns). Serum fT3 level and fT3/fT4 ratio were significantly lower (P < 0.001) in late-life group only in ESRD. Reference values calculated for midlife ESRD patients, such as 0.6-1.3 ng/dl for fT4 compared with 0.8-1.7 ng/dl for healthy control, were helpful for the diagnosis of mild but definite hyperthyroidism in whom serum fT4 level was 1.5 ng/dl. The prevalence of primary thyroid dysfunction, compared with the values for ESRD, was 0.7 % for hyperthyroidism, 1.4 % for overt hypothyroidism and 10.3 % for subclinical hypothyroidism. Hypothyroid score was high among those with ESRD independent of thyroid dysfunction.
CONCLUSIONS: Serum fT4 level was markedly lower without a change in fT3/fT4 ratio in ESRD. This may suggest typical carbohydrate-sufficient non-thyroidal illness. The specific reference values for ESRD were useful to evaluate borderline thyroid dysfunction and to evaluate the prevalence of the patients with primary thyroid dysfunction in ESRD.

Entities:  

Keywords:  End-stage renal disease (ESRD); Hyperthyroidism; Hypothyroidism; Non-thyroidal illness (low triiodothyronine syndrome) (NTI); Thyroid-stimulating hormone (TSH)

Mesh:

Substances:

Year:  2014        PMID: 24996935     DOI: 10.1007/s40618-014-0121-6

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  50 in total

1.  Endocrine abnormalities in patients undergoing long-term hemodialysis. The role of prolactin.

Authors:  F Gómez; R de la Cueva; J P Wauters; T Lemarchand-Béraud
Journal:  Am J Med       Date:  1980-04       Impact factor: 4.965

Review 2.  Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability.

Authors:  G Hennemann; R Docter; E C Friesema; M de Jong; E P Krenning; T J Visser
Journal:  Endocr Rev       Date:  2001-08       Impact factor: 19.871

3.  Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness.

Authors:  E Fliers; S E Guldenaar; W M Wiersinga; D F Swaab
Journal:  J Clin Endocrinol Metab       Date:  1997-12       Impact factor: 5.958

4.  Abnormalities of thyrotrophin (TSH) evening rise and pulsatile release in haemodialysis patients: evidence for hypothalamic-pituitary changes in chronic renal failure.

Authors:  T Wheatley; P M Clark; J D Clark; R Holder; P R Raggatt; D B Evans
Journal:  Clin Endocrinol (Oxf)       Date:  1989-07       Impact factor: 3.478

5.  Thyroid hormone metabolism and thyroid diseases in chronic renal failure.

Authors:  E M Kaptein
Journal:  Endocr Rev       Date:  1996-02       Impact factor: 19.871

6.  A sensitive thyroid stimulating hormone assay for screening of thyroid functional disorder in elderly Japanese.

Authors:  K Okamura; K Ueda; H Sone; H Ikenoue; Y Hasuo; K Sato; M Yoshinari; M Fujishima
Journal:  J Am Geriatr Soc       Date:  1989-04       Impact factor: 5.562

7.  Thyroid function in patients undergoing maintenance hemodialysis: unexplained low serum thyroxine concentration.

Authors:  J M Hershman; L G Krugman; J D Kopple; A W Reed; M Azukizawa; J H Shinaberger
Journal:  Metabolism       Date:  1978-07       Impact factor: 8.694

8.  Variable thyrotropin response to thyrotropin-releasing hormone after small decreases in plasma free thyroid hormone concentrations in patients with nonthyroidal diseases.

Authors:  S J Maturlo; R L Rosenbaum; C Pan; M I Surks
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

9.  Thyroid function in a uremic rat model. Evidence suggesting tissue hypothyroidism.

Authors:  V S Lim; C Henriquez; H Seo; S Refetoff; E Martino
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

10.  Masked hyperthyroidism in a haemodialysis patient successfully treated by potassium iodide.

Authors:  Toru Sanai; Ken Okamura; Kaori Sato; Syuichi Rikitake; Tomoya Kishi; Motoaki Miyazono; Yuji Ikeda
Journal:  Clin Kidney J       Date:  2012-01-30
View more
  4 in total

1.  Subclinical hypothyroidism and diabetic nephropathy in Iranian patients with type 2 diabetes.

Authors:  N Mansournia; S Riyahi; S Tofangchiha; M A Mansournia; M Riahi; Z Heidari; E Hazrati
Journal:  J Endocrinol Invest       Date:  2016-10-13       Impact factor: 4.256

2.  Hypothyroidism in hospitalized elderly patients: a sign of worse prognosis.

Authors:  N Sforza; J Rosenfarb; R Rujelman; M Rosmarin; E Blanc; C Frigerio; P Fossati; D Caruso; C Faingold; T Meroño; G Brenta
Journal:  J Endocrinol Invest       Date:  2017-05-22       Impact factor: 4.256

3.  Identification of physical and psychosocial problems associated with diabetic nephropathy using the International Classification of Functioning, Disability and Health Core Set for Diabetes Mellitus.

Authors:  Hideyo Tsutsui; Kyoko Nomura; Takayoshi Ohkubo; Nobuaki Ozaki; Masataka Kusunoki; Tetsuya Ishiguro; Yoshiharu Oshida
Journal:  Clin Exp Nephrol       Date:  2015-07-04       Impact factor: 2.801

4.  Evaluation of oxidative stress and thyroid hormone status in hemodialysis patients in Gorgan.

Authors:  Javad Velayeti; Azad Reza Mansourian; Mohammad Mojerloo; Abdoljalal Marjani
Journal:  Indian J Endocrinol Metab       Date:  2016 May-Jun
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.